Interestingly, we discovered that MT-ATP8 expression levels were associated with disease severity; in particular, the two COVID-19 patients receiving ECMO had near-zero MT-ATP8 expression compared to the no-ECMO patient and the healthy control. Here, MT-ATP8 is linked to COVID-19.